Press kit
Need for new inhaler
Respimat® Soft Mist™ Inhaler: The need for a new inhaler device. The clinical success of a medication depends upon its efficacy, tolerability and, since compliance is a significant issue, its acceptability to patients.
New generation inhaler
Boehringer Ingelheim, with its experience in modern device technology coupled with extensive experience in the development of respiratory drugs, takes a significant step forward for inhaler therapy by launching the first Respimat® product, Berodual® Respimat®, in Germany in early 2004.
Technical background
Respimat® Soft Mist™ Inhaler (SMI), developed by Boehringer Ingelheim, is a propellant-free, new generation inhaler that represents a major step forward in inhalation therapy.
© 2012 Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
